Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: FTSE 100 nears one-month high

Tue, 10th Sep 2013 11:39

Receding fears about a potential US military strike on Syria and decent data from China lifted UK stocks on Thursday morning, with the FTSE 100 rising to levels not seen in nearly a month.London's benchmark index was up 0.8% at 6,581.91 by midday; the last time it closed higher was on August 14th when it ended the day at 6,587.43.Russian Foreign Minister Sergei Lavrov yesterday urged Syria to place any chemical weapons they may have under international control in an attempt to avoid action from the States. The news that Syrian counterpart Walid Muallem apparently welcomed the proposal eased concerns over a possible Western intervention this morning, especially given that President Barack Obama said that he would put air strikes on hold if Bashar al-Assad's government follows the initiative."Stocks rallied on the back of this, as investors don't want another war on their hands, and this recommendation from the Russians could sidestep military intervention while saving face," said Market Analyst David Madden from IG.Supporting stocks further was a continuing improvement in economic data from China with the third-quarter outlook for the Asian powerhouse continuing to brighten. Industrial output, fixed-asset investment and retail sales strengthened during the month of August, with all three economic indicators rising by more than expected.Market Strategist Ishaq Siddiqi from ETX Capital said that this morning's data "indicat[es] the world's second-largest economy is finally back above its knees after a turbulent first half of 2013.""China's policymakers are attempting to transform the country's economy into one based on consumption over the current model based on spending and the macro indicators are suggesting that these measures are starting to bear fruit," he said.FTSE 100: Airlines IAG and easyJet flying highAirline groups IAG and easyJet were flying higher this morning as crude continued to pull back from its recent highs as fears over turmoil in the Middle East ease. Elevated oil prices have pressured both stocks over the last few weeks on concerns over the knock-on effects to jet fuel costs. Shares in easyJet were also helped by comments from Chief Executive Carolyn McCall who said in an interview that the company will be "Europe's preferred airline in five years' time" due to its low-cost operating model.Financials were also performing well today with RBS, Standard Chartered, Aviva, Aberdeen Asset Management and Schroders among the highest risers.Leading the downside was pharma giant GlaxoSmithKline which fell sharply after US regulators set out requirements for generic versions of its lung drug Advair, sparking competition concerns over when patents run out in a few years' time.Costa and Premier Inn owner Whitbread was also down after seeing sales growth slow from 13.8% in the first quarter to just 10.8% in the second as the hot summer weather hit demand at its coffee shops.Miners were putting in a mixed performance as increased risk appetite was offset by falling metals prices across the board. Glencore Xstrata was in demand after lifting its synergy target - following its merger - to at least $2bn next year as the miner vowed to cut costs and improve operational efficiency. Precious metals groups Fresnillo and Randgold, however, were out of favour. Rolls-Royce gained after scoring a $175m contract with Asia Gas Pipeline (AGP) for services on a natural gas pipeline in Kazakhstan.Broker comments were also moving a number of blue-chip stocks this morning: Drinks giant SABMiller was on the climb this morning after HSBC upgraded the stock to 'overweight'; consumer products group Unilever was lifted by Deutsche Bank to 'buy'; and Babcock was higher after JPMorgan labelled the engineering support services company as its top pick in the sector.FTSE 250: Ashmore jumps, Oxford Instruments slumpsRecord subscriptions helped emerging markets asset manager Ashmore to drive strong net inflows into its funds in the year to June, giving the share price a boost this morning. Strong net inflows of $13.4bn led to a 22% increase in assets under management (AuM) to $77.4bn during the year, with average AuM rising 13%.Oxford Instruments was a heavy faller after saying that while growth in the order intake rate in Industrial Products and third party Service is encouraging, slowness in R&D markets in the Western economies means that the year is likely to be more second half-weighted.FTSE 100 - RiserseasyJet (EZJ) 1,335.00p +5.37%International Consolidated Airlines Group SA (CDI) (IAG) 319.50p +4.58%Standard Chartered (STAN) 1,502.00p +3.19%Royal Bank of Scotland Group (RBS) 350.80p +3.18%Aviva (AV.) 412.10p +3.08%Aberdeen Asset Management (ADN) 380.40p +3.03%British Land Co (BLND) 574.00p +2.96%Glencore Xstrata (GLEN) 330.10p +2.74%Schroders (SDR) 2,486.00p +2.64%Marks & Spencer Group (MKS) 513.00p +2.50%FTSE 100 - FallersGlaxoSmithKline (GSK) 1,590.00p -3.05%Whitbread (WTB) 3,129.00p -2.71%Fresnillo (FRES) 1,249.00p -1.58%Eurasian Natural Resources Corp. (ENRC) 222.60p -0.98%Randgold Resources Ltd. (RRS) 4,869.00p -0.92%Vodafone Group (VOD) 209.00p -0.67%BG Group (BG.) 1,213.00p -0.33%Bunzl (BNZL) 1,353.00p -0.29%BP (BP.) 443.00p -0.25%Vedanta Resources (VED) 1,189.00p -0.08%FTSE 250 - RisersOcado Group (OCDO) 374.20p +6.91%Ashmore Group (ASHM) 387.60p +6.81%Fenner (FENR) 390.40p +5.26%Thomas Cook Group (TCG) 157.50p +5.07%Inchcape (INCH) 641.00p +4.74%Ferrexpo (FXPO) 186.60p +4.42%Laird (LRD) 233.30p +4.34%Galliford Try (GFRD) 1,066.00p +4.20%Berendsen (BRSN) 940.50p +3.75%Betfair Group (BET) 1,050.00p +3.55%FTSE 250 - FallersOxford Instruments (OXIG) 1,423.00p -5.76%African Barrick Gold (ABG) 175.00p -4.68%Rank Group (RNK) 155.00p -2.58%PayPoint (PAY) 1,086.00p -1.63%Moneysupermarket.com Group (MONY) 170.00p -1.33%BH Macro Ltd. EUR Shares (BHME) € 20.78 -1.28%Telecom Plus (TEP) 1,337.00p -1.26%Telecity Group (TCY) 836.50p -1.18%BH Macro Ltd. GBP Shares (BHMG) 2,140.00p -1.02%BH Global Ltd. GBP Shares (BHGG) 1,181.00p -1.01%BC
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.